Alnylam Pharmaceuticals (ALNY) PT Raised to $206 at Leerink Partners
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $225.06 -1.57%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $206.00 (from $200.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo
- Rakus Co Ltd (3923:JP) PT Raised to JPY1,300 at Macquarie
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
